BY GOOD NEWS NETWORK: A compound found in tomatoes may offer a new way to fight diabetes, scientists have discovered.
Research funded by the French government has shown that lycopene, the substance which gives tomatoes their red color, fights the inflammatory process that causes the condition.
Now a €500,000 ($568,000) research project is being planned to produce a modified lycopene pill to be used in human trials.
The French team led by Dr. Jean-Francois Landrier, director of the French National Health Research Institute’s cardiovascular and nutritional health division at Marseille University, has shown that lycopene dampens down this inflammatory process and slows the development of resistance to insulin signaling. (read more)
BY ANA SANDOIU: Many people take statins to lower cholesterol and reduce the risk of cardiovascular events, such as coronary heart disease and heart attacks. In the United States, about 83% of people between 40 and 59 years of age who take cholesterol-lowering medication are taking statins.
Although statins are effective at staving off cardiovascular disease, some previous trials have suggested that they may raise the risk of diabetes. (read more)
BY MEDICAL SCIENCE NEWS: Early research suggests that the common pantry staple baking soda affects inflammation and insulin handling in type 2 diabetes. The findings will be presented today at the American Physiological Society (APS)/American Society of Nephrology (ASN) conference, Control of Renal Function in Health and Disease in Charlottesville, Va.
Obesity-induced inflammation is thought to be a cause of insulin resistance- the inability of the body to respond to insulin properly- which can lead to type 2 diabetes. The immune system- including the spleen, a small organ located behind the stomach- activates to fight chronic inflammation. (read more)
BY SERENA GORDON: Children diagnosed with type 1 diabetes at an early age have slowed growth in brain areas linked to mild cognitive deficits, new research suggests.
The study compared MRIs of the brain in kids with type 1 diabetes to age-matched children without the condition. Researchers also saw that areas of slower brain growth were associated with higher average blood sugar levels.
“We found significant detectable and persistent differences in the volume of different brain areas that participate in a lot of cognitive functions. There was slower growth across the board in the brain,” said Dr. Nelly Mauras, co-principal investigator of the study. She’s chief of the division of pediatric endocrinology at Nemours Children’s Health System in Jacksonville, Fla. (read more)
BY BRIAN MASTROIANNI: At the American Diabetes Association’s 79th Scientific Sessions in early June, IBM and JDRF (formerly known as the Juvenile Diabetes Research Foundation), a nonprofit that spearheads Type 1 diabetes research, unveiled a predictive AI tool that has mapped the presence of Type 1 diabetes antibodies in blood to figure out exactly when and how the condition could develop. Jianying Hu, IBM fellow and global science leader of AI for health care at IBM Research, told Engadget that the AI was fed data from more than 22,000 people from the United States, Sweden and Finland.
The program pinpointed similarities among people with specific antibodies for the disease and the timeline of their Type 1 diabetes progression. (read more)